Document is current
Any future updates will be listed below
-
Authors
Lu, Xiameng
Zhu, Liru
Tan, Bibo
Liang, Zhuowei
Chen, Kaihua
Huang, Suning
Li, Ling
Zhu, Xiaodong
-
Funding
Funding for this research was provided by:
Guangxi Key Research and Development Program (GuikeAB23026020)
Natural Science Foundation of Guangxi Zhuang Autonomous Region (2023GXNSFBA026012)
- License Information
-
More Information
Article History
Received: 10 April 2025
Accepted: 18 August 2025
First Online: 2 October 2025
Declarations
:
: This study was approved by the Ethics Committee of Guangxi Medical University Cancer Hospital, in compliance with the Declaration of Helsinki. This study involved anonymized patient data and, due to its retrospective nature, was exempt from the requirement for informed consent. Informed consent was obtained from all participants during their initial treatment. The data used in this study were anonymized to ensure patient confidentiality.
: Patient consent was waived due to the use of anonymized retrospective data.
: The authors declare no competing interests.
